Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 4
2002 3
2003 2
2004 7
2005 12
2006 15
2007 24
2008 27
2009 16
2010 8
2011 14
2012 13
2013 16
2014 14
2015 19
2016 12
2017 16
2018 19
2019 17
2020 16
2021 14
2022 14
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Results by year

Filters applied: . Clear all
The following terms were ignored: "", OR
Quoted phrases not found in phrase index: "170098-38-1"
Page 1
Postoperative ileus-An ongoing conundrum.
Wattchow D, Heitmann P, Smolilo D, Spencer NJ, Parker D, Hibberd T, Brookes SSJ, Dinning PG, Costa M. Wattchow D, et al. Neurogastroenterol Motil. 2021 May;33(5):e14046. doi: 10.1111/nmo.14046. Epub 2020 Nov 30. Neurogastroenterol Motil. 2021. PMID: 33252179 Review.
Postoperative ileus: Recent developments in pathophysiology and management.
Bragg D, El-Sharkawy AM, Psaltis E, Maxwell-Armstrong CA, Lobo DN. Bragg D, et al. Clin Nutr. 2015 Jun;34(3):367-76. doi: 10.1016/j.clnu.2015.01.016. Epub 2015 Jan 31. Clin Nutr. 2015. PMID: 25819420 Review.
Evidence is supportive of thoracic epidural analgesia, avoidance of salt and water overload, alvimopan and gum chewing as measures for the prevention of POI, and should be incorporated into perioperative care protocols. ...
Evidence is supportive of thoracic epidural analgesia, avoidance of salt and water overload, alvimopan and gum chewing as measures fo …
Structure determination of inactive-state GPCRs with a universal nanobody.
Robertson MJ, Papasergi-Scott MM, He F, Seven AB, Meyerowitz JG, Panova O, Peroto MC, Che T, Skiniotis G. Robertson MJ, et al. Nat Struct Mol Biol. 2022 Dec;29(12):1188-1195. doi: 10.1038/s41594-022-00859-8. Epub 2022 Nov 17. Nat Struct Mol Biol. 2022. PMID: 36396979
Using this approach, we obtained structures of neurotensin 1 receptor bound to antagonist SR48692, mu-opioid receptor bound to alvimopan, apo somatostatin receptor 2 and histamine receptor 2 bound to famotidine. ...
Using this approach, we obtained structures of neurotensin 1 receptor bound to antagonist SR48692, mu-opioid receptor bound to alvimopan …
Postoperative Ileus.
Harnsberger CR, Maykel JA, Alavi K. Harnsberger CR, et al. Clin Colon Rectal Surg. 2019 May;32(3):166-170. doi: 10.1055/s-0038-1677003. Epub 2019 Apr 2. Clin Colon Rectal Surg. 2019. PMID: 31061645 Free PMC article. Review.
There is significant evidence to suggest that a minimally invasive approach and multimodal pain regimens reduce the development of POI. The beneficial effect of chewing gum, alvimopan, and enhanced recovery after surgery protocols may decrease development of POI in selecte …
There is significant evidence to suggest that a minimally invasive approach and multimodal pain regimens reduce the development of POI. The …
Alvimopan.
Curran MP, Robins GW, Scott LJ, Perry CM. Curran MP, et al. Drugs. 2008;68(14):2011-9. doi: 10.2165/00003495-200868140-00006. Drugs. 2008. PMID: 18778122 Review.
The mean time to reach the GI2 endpoint was 11-26 hours sooner with alvimopan than with placebo. In the phase III trials conducted in North America, the time to writing the hospital discharge order was 13-21 hours sooner with alvimopan than with placebo. ...Short-te …
The mean time to reach the GI2 endpoint was 11-26 hours sooner with alvimopan than with placebo. In the phase III trials conducted in …
Alvimopan for postoperative ileus.
Bream-Rouwenhorst HR, Cantrell MA. Bream-Rouwenhorst HR, et al. Am J Health Syst Pharm. 2009 Jul 15;66(14):1267-77. doi: 10.2146/ajhp080445. Am J Health Syst Pharm. 2009. PMID: 19574601 Review.
PURPOSE: The efficacy, safety, pharmacology, pharmacokinetics, drug-drug interactions, and administration of alvimopan for postoperative ileus are reviewed. SUMMARY: Alvimopan is a selective mu-opioid receptor antagonist with no central nervous system activity. ...T …
PURPOSE: The efficacy, safety, pharmacology, pharmacokinetics, drug-drug interactions, and administration of alvimopan for postoperat …
Alvimopan for recovery of bowel function after radical cystectomy.
Sultan S, Coles B, Dahm P. Sultan S, et al. Cochrane Database Syst Rev. 2017 May 2;5(5):CD012111. doi: 10.1002/14651858.CD012111.pub2. Cochrane Database Syst Rev. 2017. PMID: 28462518 Free PMC article. Review.
BACKGROUND: Alvimopan is used in abdominal surgery to reduce postoperative ileus in patients undergoing small bowel resections with primary anastomosis. The role and efficacy of alvimopan in patients undergoing radical cystectomy with urinary diversion is not well u …
BACKGROUND: Alvimopan is used in abdominal surgery to reduce postoperative ileus in patients undergoing small bowel resections with p …
An update on analgesics.
Power I. Power I. Br J Anaesth. 2011 Jul;107(1):19-24. doi: 10.1093/bja/aer126. Epub 2011 May 30. Br J Anaesth. 2011. PMID: 21624966 Free article. Review.
Opioid antagonists have received much attention recently either used alone, methylnaltrexone (s.c) or alvimopan (p.o), or in combination, Targinact (oxycodone/naloxone), and appear to be effective in reducing opioid side-effects such as those in the gastrointestinal tract. …
Opioid antagonists have received much attention recently either used alone, methylnaltrexone (s.c) or alvimopan (p.o), or in combinat …
Outcomes of Alvimopan Use in Laparoscopic Intra-abdominal Surgery: A Retrospective Review.
Kokan AA, Sheth S, Rogers K. Kokan AA, et al. Innov Pharm. 2021 Sep 22;12(4):10.24926/iip.v12i4.3969. doi: 10.24926/iip.v12i4.3969. eCollection 2021. Innov Pharm. 2021. PMID: 36033128 Free PMC article.
The objective of this study was to assess the impact of alvimopan use in laparoscopic abdominal surgeries. Objective: To assess alvimopan use's impact in laparoscopic abdominal surgeries. Methods: A retrospective chart review was conducted of 84 patients who underwe …
The objective of this study was to assess the impact of alvimopan use in laparoscopic abdominal surgeries. Objective: To assess al …
Opioid-induced bowel dysfunction.
Thomas J. Thomas J. J Pain Symptom Manage. 2008 Jan;35(1):103-13. doi: 10.1016/j.jpainsymman.2007.01.017. Epub 2007 Nov 5. J Pain Symptom Manage. 2008. PMID: 17981003 Free article. Review.
Systemic opioid antagonists administered orally can induce laxation, but can unpredictably induce systemic or local GI tract withdrawal symptoms. Two new investigational agents, alvimopan and methylnaltrexone, are peripherally acting opioid antagonists that do not cross th …
Systemic opioid antagonists administered orally can induce laxation, but can unpredictably induce systemic or local GI tract withdrawal symp …
269 results